Ophtherix, Inc.
Ophtherix develops novel ophthalmic products designed to treat a wide range of common eye disorders, including glaucoma and high axial myopia. We aim to provide improved treatment options for preserving vision to patients and physicians worldwide.
| Startup type: | University Spin-out |
| Status: | Active |
| Publicity: | Stealth mode. No media please. |
OUR NEWS
Long ago
|
|
28 January 2009
James Su created the startup |
|
Biomedical Engineering graduate from The Johns Hopkins University, with MEng from UC San Diego. Currently pursuing PhD at Berkeley.
|
THINGS WE NEED
The Ophtherix, Inc. team hasn't posted any needs yet.